HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Simon M Y Lee Selected Research

cucurbit(7)uril

9/2018Supramolecular strategy for reducing the cardiotoxicity of bedaquiline without compromising its antimycobacterial efficacy.
1/2018Supramolecular Encapsulation and Bioactivity Modulation of a Halonium Ion by Cucurbit[ n]uril ( n = 7, 8).
10/2017Supramolecular alleviation of cardiotoxicity of a small-molecule kinase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Simon M Y Lee Research Topics

Disease

4Neoplasms (Cancer)
10/2017 - 01/2012
3Cardiotoxicity
09/2018 - 10/2017
3Parkinson Disease (Parkinson's Disease)
12/2015 - 01/2012
2Inflammation (Inflammations)
01/2022 - 01/2020
2Atherosclerosis
01/2022 - 01/2020
2Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
12/2020 - 09/2018
2Pheochromocytoma
02/2015 - 07/2012
1Atherosclerotic Plaque (Atheroma)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1COVID-19
10/2021
1Neuroinflammatory Diseases
01/2018
1Breast Neoplasms (Breast Cancer)
08/2017
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2017
1Ischemic Stroke
11/2016
1Stroke (Strokes)
11/2016
1Cerebral Infarction
11/2016
1Infarction (Infarctions)
11/2016
1Osteoporosis
11/2015
1Cardiovascular Diseases (Cardiovascular Disease)
08/2015
1Ulcer
01/2012
1Wounds and Injuries (Trauma)
01/2012
1Nerve Degeneration
01/2012
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2012
1Alzheimer Disease (Alzheimer's Disease)
12/2007

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
01/2020 - 01/2012
3Artificial ReceptorsIBA
09/2018 - 10/2017
3cucurbit(7)urilIBA
09/2018 - 10/2017
3Proteins (Proteins, Gene)FDA Link
11/2016 - 07/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2017 - 03/2017
2AlginatesIBA
08/2017 - 03/2017
2Neuroprotective AgentsIBA
11/2016 - 08/2012
2Peptides (Polypeptides)IBA
02/2015 - 07/2012
1Liposomes (Liposome)IBA
01/2022
1Liver X ReceptorsIBA
01/2022
1CholesterolIBA
01/2022
1CyclodextrinsIBA
01/2022
1Antiviral Agents (Antivirals)IBA
10/2021
1Chloroquine (Aralen)FDA LinkGeneric
10/2021
1Antimalarials (Antimalarial Agents)IBA
10/2021
1Clofazimine (Lamprene)FDA Link
12/2020
1CytokinesIBA
01/2020
1Excipients (Suspending Agents)IBA
09/2018
1bedaquiline (R207910)IBA
09/2018
1Antitubercular AgentsIBA
09/2018
1cucurbit(n)uril (cucurbituril)IBA
01/2018
1Betulinic AcidIBA
01/2018
1cucurbit(8)urilIBA
01/2018
1diphenyleneiodoniumIBA
01/2018
1Sorafenib (BAY 43-9006)FDA Link
10/2017
1Phosphotransferases (Kinase)IBA
10/2017
1CurcuminIBA
08/2017
1SolutionsIBA
08/2017
1Schiff Bases (Schiff Base)IBA
08/2017
1ProdrugsIBA
08/2017
1Glutathione (Reduced Glutathione)IBA
03/2017
1DisulfidesIBA
03/2017
1sailuotongIBA
01/2017
1Therapeutic UsesIBA
11/2016
1VimentinIBA
11/2016
1tetramethylpyrazineIBA
11/2016
1tetramethylpyrazine nitroneIBA
11/2016
1Free RadicalsIBA
11/2016
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2015
1VitaminsIBA
11/2015
1Plant ExtractsIBA
08/2015
1ProteomeIBA
02/2015
1baicaleinIBA
08/2012
1FlavonoidsIBA
08/2012
1Oxidopamine (6 Hydroxydopamine)IBA
01/2012
1Collagen Type I (Type I Collagen)IBA
01/2012
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2012
1Semaxinib (SU5416)IBA
01/2012
1AcetylcholinesteraseIBA
12/2007

Therapy/Procedure

5Therapeutics
01/2022 - 01/2012
2Drug Therapy (Chemotherapy)
01/2020 - 08/2017
1Hydrocolloid Bandages (Duoderm)
01/2012